---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-021525"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2025-11-10T23:59:59+00:00"
generated_at: "2026-05-16T22:37:26.988066+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Biofrontera regains Nasdaq compliance on stockholders' equity and bid price rules

## Summary
- Received Nov 4 notice from Nasdaq confirming compliance with Rule 5550(b)(1) (stockholders' equity).
- Received Nov 6 notice confirming compliance with Rule 5550(a)(2) (minimum bid price ≥$1.00 for 11 consecutive days).
- Company previously disclosed deficiencies on May 21 and May 8, 2025 respectively.
- Nasdaq notes company may be subject to delisting if fails to evidence compliance upon next periodic report.

## SEC filing metadata
- accession: 0001493152-25-021525
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2025-11-10T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315225021525/0001493152-25-021525-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315225021525/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-021525
- JSON: https://secwatch.observer/filing/0001493152-25-021525.json
- Plain text: https://secwatch.observer/filing/0001493152-25-021525.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.